Inclusion criteria, exclusion criteria and study summary
RESEARCH QUESTION: In post-menopausal women who will not require chemotherapy for >T1,strongly ER+,HER2- invasive breast cancer,does NET improve global HRQoL over 15 months and increase breast BCS rates? Patients will be randomised 1:1 to either the intervention (NET) arm (6 +/- 1 months of NET followed by surgery and adjuvant ET) or the control arm (2-4 weeks of presurgical NET and surgery within 2-4 weeks [up to 8 weeks permitted for trial purposes] followed by adjuvant ET). Both arms will receive the same treatments (surgery,ET,and radiotherapy where indicated),but the sequencing of surgery will differ; both arms starting ET at randomisation,with 6 months +/- 1 month of the course of ET delivered prior to surgery in the NET arm.